688117 聖諾生物
按盤價 
20.470 -4.090 (-16.653%) | 2026/06 - 中期 | 2025/12 | 2024/12 | 2023/12 | 2022/12 | 盈利能力分析 |
| 淨資產收益率 ROE (%) | 12.282 | 15.985 | 5.564 | 8.243 | 8.001 |
| 總資產報酬率 ROA (%) | 6.748 | 8.817 | 3.376 | 5.804 | 6.247 |
| 投入資產回報率 ROIC (%) | 7.529 | 9.837 | 3.796 | 6.684 | 7.241 | 邊際利潤分析 |
| 銷售毛利率 (%) | 58.733 | 57.655 | 57.966 | 63.761 | 65.470 |
| 營業利潤率 (%) | 31.060 | 27.237 | 13.608 | 18.643 | 18.407 |
| 息稅前利潤/營業總收入 (%) | 33.084 | 27.795 | 15.504 | 19.547 | 17.896 |
| 淨利潤/營業總收入 (%) | 26.652 | 21.295 | 10.927 | 16.166 | 16.296 | 收益指標分析 |
| 經營活動淨收益/利潤總額(%) | 102.682 | 111.179 | 119.302 | 96.783 | 101.844 |
| 價值變動淨收益/利潤總額(%) | 0.020 | 1.165 | 3.045 | -1.774 | 3.407 |
| 營業外收支淨額/利潤總額(%) | -0.114 | -6.779 | -0.897 | -1.223 | -0.659 | 償債能力分析 |
| 流動比率 (X) | 1.969 | 1.407 | 1.322 | 2.525 | 2.960 |
| 速動比率 (X) | 1.195 | 0.870 | 0.761 | 1.720 | 2.358 |
| 資產負債率 (%) | 44.800 | 45.331 | 44.273 | 33.109 | 25.385 |
| 帶息債務/全部投入資本 (%) | 34.283 | 33.135 | 37.644 | 23.452 | 11.966 |
| 股東權益/帶息債務 (%) | 179.409 | 184.324 | 164.911 | 324.497 | 728.473 |
| 股東權益/負債合計 (%) | 123.214 | 120.602 | 125.873 | 201.990 | 293.929 |
| 利息保障倍數 (X) | 16.064 | 12.152 | 7.684 | 17.315 | -45.787 | 營運能力分析 |
| 應收賬款周轉天數 (天) | 50.810 | 60.446 | 82.643 | 86.151 | 92.325 |
| 存貨周轉天數 (天) | 315.399 | 367.444 | 468.610 | 376.514 | 311.938 |
| 備註： | 即時報價更新時間為 22/09/2026 13:32 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
